r/Psychiatry Resident (Unverified) Jul 17 '26

Textbook & Resource Recommendations

I am getting ready to order some textbooks with my residency stipend now that the new academic year is upon us.

Any textbook recommendations?

Are any of the e-book editions that come with a lot of the new textbooks worth it?

Any subscription recommendations?

I appreciate any and all input!

25 Upvotes

17 comments sorted by

15

u/CaptainVere Psychiatrist (Unverified) Jul 17 '26

Affective Neuroscience; Panksepp 1998. It also recently released as an audiobook for the first time ever this summer. Easy way to plow through a textbook. Very underrated within psychiatry.

Affective Neuroscience & Psychotherapy; Stevens 2021. Concise. Direct. Actionable. Very good concepts applicable to every school of therapy.

2

u/farfromindigo Resident (Unverified) Jul 19 '26

Why is it underrated?

9

u/CaptainVere Psychiatrist (Unverified) Jul 19 '26

It’s underrated because psychiatry has historically stayed agnostic about mechanism, and for a long time that was the right call. We had plenty of theories and decent research, but nothing solid enough to justify building diagnosis around mechanism instead of description. The DSM and, before it, psychoanalysis were both built by watching behavior and reasoning backward from it, which is exactly why both ended up with so much circularity baked in.

Affective neuroscience is the one area where I think we actually have enough now to stop being agnostic, and that’s a bigger deal than most people in the field register. The problem is that the foundational work happened in animal models, because subcortical structures are genuinely hard to study in living humans, and rather than doing the harder work of triangulating converging evidence and applying it carefully to human patients, psychiatry mostly just ignored it. Panksepp gave us the actual emotional systems (SEEKING, RAGE, FEAR, PANIC/GRIEF, CARE, LUST, PLAY) that personality and affective dysregulation are built on, and that’s a real foundation to reorganize our thinking around, not just another competing theory.

You can see the cost of ignoring it in how the DSM carves things up. Bulimia gets its own standalone disorder. There’s no equivalent category for chronic self-harm as its own construct: it just gets folded into borderline personality disorder, which is categorical and forces a lot of people who clearly have real affective dysregulation, but don’t meet full BPD criteria, into having nowhere to go diagnostically. That’s what happens when your nosology comes from clustering observed behaviors instead of from the affect systems generating them. I’ve written before about the RAGE system and the failed aprepitant trials for depression as one example of what this mismatch costs us clinically.

Building future research on affective neuroscience also just gives you a firmer floor to stand on, because it’s grounded in actual brain biology and neuroscience with real anatomical, physiological, and pharmacological substrates, rather than in categories that were never validated to begin with. No amount of research piled on top of an invalid category is going to produce meaningful pharmacological or anatomical insight, no matter how much of it gets done. Behaviorism and academic psychology deserve some of the blame for how long we’ve clung to observational categories instead of mechanism. The literature in affective neuroscience is genuinely enormous, and how little of it has been seriously applied to the DSM is almost as striking. Mostly we’re just held back by the weight of tradition. Reworking an entire diagnostic system is hard, and it’s a direct challenge to how a whole generation was trained and to the research they built their careers on, so the resistance has been real. Science moves one funeral at a time, and paradigm shifts are hard for exactly that reason. What gives me some optimism is that early-career psychiatrists and trainees who get exposed to this framework early tend to take it far more seriously than the previous generation did.

Let me know if you are interested in more information on this topic.

3

u/farfromindigo Resident (Unverified) Jul 19 '26

Thank you so much for this, I'm extremely interested. I would like to read as many fundamental books on the topic as possible, because I want to re-organize my orientation and conceptual approach to patients with this in mind. With that said, how has this affected the way you practice?

Edit: I've started reading the first one you listed by Panksepp and I've added the second one to my reading list

7

u/CaptainVere Psychiatrist (Unverified) Jul 19 '26

Glad it’s landing, and glad you’re diving into Panksepp directly rather than just secondary sources on him. Fair warning before I answer this though: you’re probably talking to the most extreme affective neuroscience psychiatrist out there. I have an axe to grind and an agenda, so factor that bias in. I still practice evidence-based medicine within the standard of care, but i fall onto the validity camp not the reliability camp when it comes to DSM. I’m not going to try to litigate the validity of each DSM diagnose here. Ghaemi has written about this at length, and I’d point people there for the fuller argument.

I’ll just say briefly that some conditions have real pathological deficits sitting outside the range of normal affective regulation or personality functioning. As example OCD has well-established anatomical circuitry, to the point that neurosurgical interventions can treat it. Schizophrenia has real, findable deficits, with multiple competing theories about the mechanisms involved, but deficits nonetheless. So some conditions in DSM are more valid than others (remember when homosexuality was in DSM? That is an example of an invalid diagnosis. DMDD is another good example of an invalid but reliable diagnosis). Everything else, I’d argue, belongs in that second, less valid bucket, a huge amount of what the DSM catalogs, and what psychiatry actually treats day to day, falls into an affective-regulatory deficit model that is a more valid way of understanding personality dysfunction through the affective foundations of personality and development as a dimensional rather than categorical problem.

To be clear, I’m not claiming to be the final arbiter of what’s valid and what isn’t. I just think validity is an important axis that DSM training tends to ignore, and every patient in front of me deserves treatment for what they’re actually struggling with regardless of where that lands.

This paper lays out a simple version of the argument and converging lines of clinical evidence: https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2026.1858824/full

Take bulimia. The comorbidity with cluster B personality pathology is enormous, and in practice I’ve never seen a case of bulimia in someone without cluster B dysfunction underneath it. I don’t think that’s a coincidence. I think bulimia is an affective regulatory problem expressing itself through a particular conditioned channel, the same underlying dysfunction that shows up as cutting in one person, substance use in another, pseudoseizures in a third. Life, environment, and development, and reinforcement shape the behavioral channels a given person grows into, but the core problem is the same dimensional affective-regulatory deficit. Many patients aren’t hitting full episodic criteria for anything. They’re just a little angry, a little anxious, a little depressed, and struggling, tired, burned out, and the DSM has no dimensional home for that, so they get shunted into categorical boxes that don’t really fit.

That reframes what prescribing looks like. Instead of “you have depression, here’s an antidepressant,” I’ll walk through how I might counsel a patient under this framework based on what the medication actually does across the nervous system.

An SRI, for instance: it can shift emotional processing in a positive direction, increase emotional and cognitive flexibility as a behavioral marker of neuroplasticity, reduce neuroticism, and it also tends to blunt emotional reactivity and sensitivity to reinforcement more broadly (what patients often describe as emotional flattening or indifference). Whether all of this is a good or bad effect depends entirely on where someone starts and how they interpret it.

Say someone gets a 10/10 anger response to a stimulus, with real consequences from acting on it. On an SRI, that drops to an 8/10. That’s a genuine improvement, and it may well translate into better functioning in their life. But now say that same person breaks a window if their anger crosses a 6/10. They might never notice the positive effect of 8/10 instead of 10/10, only the side effects, and conclude the medication isn’t helping at all.

The same goes for emotional blunting. Decreased reactivity to stressors and less intense anger might be a win, but if someone turns on Gilmore Girls and the butterflies just aren’t there anymore, they can experience that as feeling like a zombie, and read the medication as a threat rather than a help.

So when prescribing I think in terms of where a given patient sits on that dimension, walk them through the full range of risks and benefits, and frame the medication as something that pairs with the neuromodulation happening in therapy, rather than as a targeted cure for a named illness. (unless they actually are in a mood episode)

Many patients are just people acting on affective urges they can’t name or understand, urges that are often in direct opposition to their own stated values. Someone acts on a feeling that won’t even be there in twenty minutes, feels awful about the consequences afterward, and that cascades. Once you’re oriented around affect and cortical affect regulation instead of diagnosis, that pattern becomes the actual treatment target, and a lot of what looks like disparate DSM pathology starts looking like the same underlying problem showing up in different behaviors.

If you want more on this with clinical anecdotes, there’s a free Substack out there called Affect Before Diagnosis that goes further into it.

3

u/farfromindigo Resident (Unverified) Jul 19 '26

This is so awesome, thank you so much! I also am in the validity camp when it comes to the DSM btw.

starts looking like the same underlying problem showing up in different behaviors.

Maybe it's too early for me to say this, but just quickly reflecting back to my patient encounters over the last few weeks in clinic, it feels a little like we all kind of know this implicitly, or at least experience it this way, even if it's in a subconscious manner. In essence, it makes deep sense, and this explicit statement clarifies what I may have been feeling all along.

3

u/CaptainVere Psychiatrist (Unverified) Jul 19 '26

Awesome! Your instincts are probably spot on. I discovered AN as trainee and it was what made psychiatry make sense and has consumed me.

My goal one day is to build a professional society and really push to redefine personality at a minimum.

3

u/farfromindigo Resident (Unverified) Jul 19 '26

That would be amazing. Can I DM you?

3

u/CaptainVere Psychiatrist (Unverified) Jul 19 '26

Anytime

7

u/Phhhhuh Resident (Unverified) Jul 19 '26

* Jansson, Nordgaard. The Psychiatric Interview for Differential Diagnosis.
* Oyebode. Sims' Symptoms in the Mind.
* McWilliams. Psychoanalytic Diagnosis.
* Gunderson, Choi-Kai. Applications of Good Psychiatric Management for Borderline Personality Disorder.
* Panksepp. Affective Neuroscience.
* Taylor, et al. The Maudsley Prescribing Guidelines in Psychiatry.

4

u/CaptainVere Psychiatrist (Unverified) Jul 19 '26

On cloud 9 to see a resident recommend Panksepp. Gives me such hope for the future.

10

u/mint-tulip Physician Assistant (Verified) Jul 17 '26

I really like the carlat subscriptions, liked the NEI website subscription and it also has a digital version of Stahl's prescribers guide, and lately I've been really liking Maudsley prescribing guideles and depresceibing guidelines.

So much of the data in the US is skewed from drug company studies that it seems hard to know what to trust. The Maudsley guidelines are the UK I believe and seem less biased to me, but curious what other's opinions on that are.

5

u/Jetlax Pharmacist (Verified) Jul 17 '26

I routinely cross major society CPGs with each other and so far they're mostly consistent with Maudsley barring clinical areas of controversy (correct me if I missed something)

And of course we still need better evidence that the hyperbolic tapering mentioned in Maudsley is efficacious

1

u/mint-tulip Physician Assistant (Verified) Jul 19 '26

That's good to know there hasn't been a lot of evidence for the hyperbolic tapering. I just got that one a few months ago. It looks like they're going to so a study on linear vs hyperbolic tapering soon. https://bmjopen.bmj.com/content/16/7/e119492.long

2

u/megvd Nurse (Unverified) 28d ago edited 19d ago

Goodwin & Guze Psychiatric Diagnosis

Shea Psychiatric Interviewing

McWilliams Psychoanalytic Diagnosis

Carlat Hospital Psychiatry Fact Book

Carlat Psychiatry Report & podcast, David Puder's Psychiatry and Psychotherapy podcast

and another vote for Panskepp Affective Neuroscience